Clinical Trial Results TV
March 24, 2012: Dr. James McKenney and Dr. Nihar R. Desai discuss: A Randomized, Double Blind, Placebo-controlled Trial of the Safety an
Dr. James McKenney and Dr. Nihar R. Desai discuss: A Randomized, Double Blind,
Placebo-controlled Trial of the Safety and Efficacy of a Monoclonal Antibody to Proprotein
Convertase Subtilisin/Kexin Type 9 Serine Protease, REGN727/SAR236553, in Patients with
Primary Hypercholesterolemia (NCT: 01288443)

Received research funding from Regeneron and/or Sanofi

[ Download video ]


Video Statistics
5 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 1 total votes.

These statistics are updated nightly. The last update ran on
05-26-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted